HMOX1 and Miyoshi myopathy: In conclusion, our data suggest that intracellular HO-1 compartmentalization rather that enzymatic activity is involved in BTZ mediated chemoresistance thus providing an important tool to improve the clinical outcome of MM patients resistant to BTZ.